| Dr Mark Gorden Martens, MD | |
|
420 S 5th Ave, Reading, PA 19611-2143 | |
| (484) 628-8333 | |
| (484) 628-8334 |
| Full Name | Dr Mark Gorden Martens |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 420 S 5th Ave, Reading, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447221510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD464152 (Pennsylvania) | Secondary |
| 207V00000X | Obstetrics & Gynecology | 25MA08692100 (New Jersey) | Primary |
| Entity Name | Hackensack Meridian Health Medical Group - Complex Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154379626 PECOS PAC ID: 0446272298 Enrollment ID: O20060109000000 |
News Archive
A detailed structural picture of a molecule that plays a key role in activating the Epstein Barr Virus in human cells has now been obtained by researchers at the European Molecular Biology Laboratory (EMBL) and the Institute of Molecular and Structural Virology (IVMS), associated with the University Joseph Fourier and the CNRS, in Grenoble.
In a result that will fundamentally change approaches to HIV prevention in Africa, an international study has demonstrated that individuals at high risk for HIV infection who took a daily tablet containing an HIV medication - either the antiretroviral medication tenofovir or tenofovir in combination with emtricitabine - experienced significantly fewer HIV infections than those who received a placebo pill.
Threshold Pharmaceuticals, Inc., today announced that the University of Texas at San Antonio initiated a clinical trial of TH-302 in combination with bevacizumab in patients with recurrent high grade astrocytoma including glioblastoma.
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
At this year's annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic, Inc. announced the global launch of a novel technology designed to provide additional protection against the risks associated with hypoglycemia.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Gorden Martens, MD Po Box 16052, Reading, PA 19612-6052 Ph: (484) 628-8333 | Dr Mark Gorden Martens, MD 420 S 5th Ave, Reading, PA 19611-2143 Ph: (484) 628-8333 |
News Archive
A detailed structural picture of a molecule that plays a key role in activating the Epstein Barr Virus in human cells has now been obtained by researchers at the European Molecular Biology Laboratory (EMBL) and the Institute of Molecular and Structural Virology (IVMS), associated with the University Joseph Fourier and the CNRS, in Grenoble.
In a result that will fundamentally change approaches to HIV prevention in Africa, an international study has demonstrated that individuals at high risk for HIV infection who took a daily tablet containing an HIV medication - either the antiretroviral medication tenofovir or tenofovir in combination with emtricitabine - experienced significantly fewer HIV infections than those who received a placebo pill.
Threshold Pharmaceuticals, Inc., today announced that the University of Texas at San Antonio initiated a clinical trial of TH-302 in combination with bevacizumab in patients with recurrent high grade astrocytoma including glioblastoma.
The longer a person took low-dose aspirin, the lower his or her risk for developing pancreatic cancer, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.
At this year's annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic, Inc. announced the global launch of a novel technology designed to provide additional protection against the risks associated with hypoglycemia.
› Verified 2 days ago
Dr. Dominic J Cammarano Iii, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3701 Perkiomen Ave, Reading, PA 19606 Phone: 610-779-6550 Fax: 610-779-8295 | |
Dr. Peter F Schnatz, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 6th Avenue And Spruce Street, Dept Of Ob/gyn - R1, Reading Hospital, Reading, PA 19612 Phone: 484-628-8827 Fax: 484-628-9292 | |
Vincent Zhang, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2494 Bernville Rd Ste 100, Reading, PA 19605 Phone: 610-378-2899 Fax: 610-378-2980 | |
Dr. Janette Gobran Ghattas, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 120 Prospect Street, Reading, PA 19606 Phone: 610-777-3330 Fax: 610-779-1844 | |
Nagi Helmi Abadier, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 N 6th St, Reading, PA 19601 Phone: 610-378-2551 | |
Dr. Christie L Ganas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 4885 Demoss Rd Ste 101, Reading, PA 19606 Phone: 610-898-7070 Fax: 610-779-3923 | |
Janet Susan Selman, CNM, RN Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 145 N 6th St, Reading, PA 19601 Phone: 610-378-2551 |